Bolt Biotherapeutics
BOLT
$4.06-4.19%
Delayed · as of Oct 16, 2026, 3:30 PM ET
Mkt cap
$11.33M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$7.70M
EPS (TTM)
$-16.51
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-433.74%
Beta
0.91
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Latest reported BOLT revenue for 2025-12-31 was $7.7M. Net income was -$33.4M. Revenue was up 0.1% from 2024-12-31 to 2025-12-31. BOLT currently screens at market cap $11.3M.
Use this BOLT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BOLT income, balance, and cash tables.
Bolt Biotherapeutics (BOLT) is a biotechnology company in the Healthcare sector.
Latest cached Bolt Biotherapeutics (BOLT) revenue for Dec 31, 2025 was $7.7M. Net income was -$33.4M. Statements: https://lician.com/financials/bolt
Bolt Biotherapeutics (BOLT) market capitalization is $11.3M on the latest cached snapshot.
Bolt Biotherapeutics (BOLT) cached previous close $4.24; day range $3.96 – $4.48; volume 9,180. Session quote: https://lician.com/quote/bolt
Bolt Biotherapeutics (BOLT) latest cached earnings event is "BOLT earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings